View Older Stories View More Recent Stories

Aug 13, 2024 04:12AM J&J wins plaintiff support for $6.5 billion baby powder settlement - Bloomberg
Aug 12, 2024 02:50PM Johnson & Johnson (JNJ) Gets Plaintiff Backing For $6.5 Billion Baby Powder Accord - Bloomberg
Aug 9, 2024 03:29AM Johnson & Johnson (JNJ) option implied volatility flat into a talc settlement draws near
Aug 8, 2024 04:00PM Upside seen for Johnson & Johnson ahead of talc vote outcome
Jul 23, 2024 03:35AM Daiwa Securities Downgrades Johnson & Johnson (JNJ) to Neutral (3)
Jul 22, 2024 08:00AM Johnson & Johnson (JNJ) seeks U.S. FDA approval of SPRAVATO as the first and only monotherapy for adults with treatment-resistant depression
Jul 18, 2024 09:17AM Johnson & Johnson (JNJ) PT Lowered to $185 at TD Cowen
Jul 18, 2024 06:14AM RBC Capital Reiterates Outperform Rating on Johnson & Johnson (JNJ)
Jul 17, 2024 01:58PM Johnson & Johnson (JNJ) PT Raised to $160 at Stifel
Jul 17, 2024 11:30AM Midday movers: Nvidia, TSMC, Five Below, Spirit Airlines and Eli Lilly fall
Jul 17, 2024 06:39AM Johnson & Johnson (JNJ) gains as Q2 earnings, revenue beat estimates
Jul 17, 2024 06:21AM Johnson & Johnson (JNJ) Tops Q2 EPS by 10c, Beats on Revenue; Offers FY24 EPS Guidance
Jul 17, 2024 06:00AM Stocks expected to have increasing option volume: JNJ ELV USB SYF CFG ALLY BE SAVE JBHT
Jul 16, 2024 11:04AM Johnson & Johnson (JNJ) call put ratio 5.5 calls to 1 put with focus on July and August 155 calls into quarter results
Jul 16, 2024 05:19AM Johnson & Johnson (JNJ) July 149 straddle into quarter results
Jul 16, 2024 04:00AM JNJ Q2 earnings preview: This is what analysts expect
Jul 12, 2024 01:45PM Legend Biotech said to have received takeover approach, hired Centerview - source
Jul 11, 2024 07:30AM Johnson & Johnson (JNJ) Announces Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
Jul 8, 2024 05:01PM Emergent BioSolutions (EBS), Johnson & Johnson (JNJ) Settle Claims Over Vaccine Manufacturing Pact - Bloomberg
Jul 3, 2024 04:55AM Johnson & Johnson (JNJ) option IV flat into 2024 elections
Jul 2, 2024 11:00PM Here are high-quality stock names that pay dividends
Jul 2, 2024 07:30AM Johnson & Johnson (JNJ) Reports CARVYKTI achieved statistically significant and clinically meaningful improvement in overall survival in landmark CARTITUDE-4 study
Jun 28, 2024 11:30AM Johnson & Johnson (JNJ) reports positive results from the nipocalimab Phase 3 Vivacity-MG3 study
Jun 28, 2024 11:08AM CHMP issues positive opinion for J&J's (JNJ) BALVERSA for unresectable or metastatic urothelial carcinoma
Jun 21, 2024 07:30AM Johnson & Johnson (JNJ) Completes Acquisition of Proteologix
Jun 20, 2024 04:31PM Johnson & Johnson (JNJ) Seeking FDA Approval of TREMFYA for Active Crohn's disease
Jun 18, 2024 09:45AM Stifel Comments on Johnson & Johnson (JNJ) Post EU Robotic Tour: 'JNJ’s laparoscopic surgery business continues to be on the losing end of robotic share gain'
Jun 17, 2024 08:02AM Johnson & Johnson (JNJ): Subcutaneous amivantamab BLA submitted to U.S. FDA for patients with EGFR-mutated non-small cell lung cancer
Jun 17, 2024 06:23AM RBC Capital Reiterates Outperform Rating on Johnson & Johnson (JNJ)
Jun 14, 2024 08:02AM Johnson & Johnson (JNJ) reports TALVEY demonstrated highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma
Jun 11, 2024 05:27AM BofA Securities Reiterates Neutral Rating on Johnson & Johnson (JNJ)
Jun 10, 2024 05:39AM RBC Capital Reiterates Outperform Rating on Johnson & Johnson (JNJ)
Apr 14, 2024 02:00PM Johnson & Johnson (JNJ) stock: 1Q24 earnings preview
View More Recent Stories View Older Stories